長期肺炎死亡率指数。市中肺炎患者の国際多施設共同での導出および検証研究
Raúl Méndez1,2,3,4, Paula González-Jiménez1,2,3, Ana Latorre2
1Pneumology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Rationale:
Long-term mortality after hospital discharge in community-acquired pneumonia (CAP) is a neglected issue. A validated, accurate score predicting mortality is needed.
Objective:
To derive and validate the Long-term Pneumonia Mortality Index (L-PMI).
Methods:
L-PMI derivation used data from a Spanish multicenter prospective study on CAP with a 1-year follow-up. A logistic regression model for predicting 1-year mortality risk was developed. Performance of the model was assessed by estimating the area under the receiver operator characteristic curve. The model was externally validated using two independent multicenter CAP cohorts from Germany and the USA, and one COVID-19 pneumonia cohort from Spain. We then derived a score from the model to ease its application.
Measurements And Main Results:
The long-term mortality rate after discharge was 6.3, 4.4, 17.4 and 3.6% in the derivation, CAPNETZ (only 6-months follow-up), USA and COVID-19 cohorts, respectively. The L-PMI included: age, smoking history, nursing home resident, Charlson comorbidity index, CURB-65 score, use of non-invasive or invasive mechanical ventilation, and in-hospital cardiovascular events. The L-PMI showed high discrimination for mortality in the derivation cohort: AUC 0.82 (95% confidence interval [0.78, 0.85]). In the validation cohorts, the AUC ranged from 0.78 (0.73, 0.83) to 0.75 (0.73, 0.77) for CAPNETZ and USA cohorts, respectively, and 0.88 (0.84, 0.93) for COVID-19 cohort. L-PMI allows classification of patients according to their mortality risk into low, intermediate, and high-risk groups.
Conclusions:
The L-PMI is a novel clinical prediction score that identifies pneumonia patients at risk of mortality up to 1 year after discharge.
関連する概念動画
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

